Investors looking for stocks in the Medical - Instruments sector might want to consider either Teleflex (TFX) or SONOVA HOLDING (SONVY) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets com ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Sc ...

Core Viewpoint - The comparison between Western Digital (WDC) and Pure Storage (PSTG) indicates that WDC is more attractive to value investors due to its stronger earnings outlook and better valuation metrics [1][3]. Valuation Metrics - WDC has a forward P/E ratio of 11.67, significantly lower than PSTG's forward P/E of 31.47 [5]. - WDC's PEG ratio is 0.85, while PSTG's PEG ratio is 1.69, suggesting WDC is more undervalued relative to its expected earnings growth [5]. - WDC's P/B ratio stands at 4.98, compared to PSTG's P/B of 14.99, further indicating WDC's relative undervaluation [6]. Zacks Rank and Style Scores - WDC holds a Zacks Rank of 1 (Strong Buy), while PSTG has a Zacks Rank of 3 (Hold), reflecting a stronger improvement in WDC's earnings outlook [3][6]. - WDC's Value grade is B, contrasting with PSTG's Value grade of F, highlighting WDC's superior valuation metrics [6].

Investors with an interest in Diversified Operations stocks have likely encountered both Marubeni Corp. (MARUY) and Federal Signal (FSS) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates an ...

Core Viewpoint - Investors in the Medical - Products sector should consider GE HealthCare Technologies (GEHC) and Agilent Technologies (A) for potential value investment opportunities [1] Group 1: Zacks Rank and Earnings Outlook - GE HealthCare Technologies has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Agilent Technologies has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system emphasizes companies with positive estimate revision trends, suggesting that GEHC has an improving earnings outlook [3] Group 2: Valuation Metrics - GEHC has a forward P/E ratio of 16.21, compared to Agilent's forward P/E of 21.33, indicating that GEHC may be undervalued [5] - The PEG ratio for GEHC is 2.80, while Agilent's PEG ratio is 3.62, further suggesting that GEHC offers better value based on expected earnings growth [5] - GEHC's P/B ratio is 3.44, significantly lower than Agilent's P/B of 5.52, reinforcing the notion of GEHC being more attractively valued [6] Group 3: Overall Value Assessment - GEHC has stronger estimate revision activity and more attractive valuation metrics than Agilent, making it the superior option for value investors at this time [7]

Core Insights - Investors in the Industrial Services sector should consider Hudson Technologies (HDSN) and SiteOne Landscape (SITE) as potential value opportunities [1] Valuation Metrics - Both HDSN and SITE have a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks [3] - HDSN has a forward P/E ratio of 20.24, while SITE has a higher forward P/E of 40.19 [5] - HDSN's PEG ratio is 0.67, suggesting better value relative to its expected EPS growth compared to SITE's PEG ratio of 2.39 [5] - HDSN's P/B ratio is 1.61, indicating a lower market value compared to its book value, while SITE's P/B ratio is 3.82 [6] - Based on these valuation metrics, HDSN earns a Value grade of A, whereas SITE receives a Value grade of C [6] Conclusion - HDSN is considered the superior value option compared to SITE based on the discussed valuation figures [7]

Core Insights - The article compares Smith & Nephew (SNN) and Stryker (SYK) to determine which stock is more attractive to value investors [1] Valuation Metrics - Smith & Nephew has a Zacks Rank of 2 (Buy), indicating an improving earnings outlook, while Stryker has a Zacks Rank of 3 (Hold) [3] - SNN's forward P/E ratio is 18.40, significantly lower than SYK's forward P/E of 28.06 [5] - SNN has a PEG ratio of 1.01, while SYK's PEG ratio is 2.75, suggesting SNN is more reasonably priced relative to its expected earnings growth [5] - SNN's P/B ratio is 2.9, compared to SYK's P/B of 6.83, indicating SNN is undervalued relative to its book value [6] - These metrics contribute to SNN's Value grade of B and SYK's Value grade of D, highlighting SNN as the superior value option [6][7]

Core Viewpoint - Investors in the Computers - IT Services sector should consider Genpact (G) and Dynatrace (DT) for potential value opportunities, with Genpact currently presenting a more favorable investment case [1] Group 1: Zacks Rank and Valuation Metrics - Genpact has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Dynatrace holds a Zacks Rank of 3 (Hold) [3] - Value investors focus on various valuation metrics, including P/E ratio, P/S ratio, earnings yield, and cash flow per share to identify undervalued companies [4] Group 2: Valuation Comparisons - Genpact's forward P/E ratio is 12.63, significantly lower than Dynatrace's forward P/E of 29.85, suggesting that Genpact is more attractively priced [5] - Genpact has a PEG ratio of 1.37, while Dynatrace's PEG ratio is 2.33, indicating that Genpact offers better value relative to its expected earnings growth [5] - Genpact's P/B ratio is 2.99 compared to Dynatrace's P/B of 5.35, further supporting the argument that Genpact is the superior value option [6]

Group 1 - Cosan (CSAN) has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while Ormat Technologies (ORA) has a Zacks Rank of 3 (Hold) [3][7] - CSAN has a forward P/E ratio of 4.12, significantly lower than ORA's forward P/E of 42.21, suggesting that CSAN may be undervalued [5] - CSAN's PEG ratio is 0.13, compared to ORA's PEG ratio of 4.22, indicating that CSAN's expected earnings growth is more favorable [5] Group 2 - CSAN has a P/B ratio of 0.34, while ORA has a P/B ratio of 2.07, further supporting the notion that CSAN is undervalued relative to its book value [6] - Based on various valuation metrics, CSAN holds a Value grade of A, whereas ORA has a Value grade of C, highlighting CSAN's superior value proposition [6] - The improving earnings outlook for CSAN makes it a more attractive option for value investors compared to ORA [7]

Company Performance - Dorman Products (DORM) has seen a significant increase in its stock price, rising 24% over the past month and reaching a new 52-week high of $150.24 [1] - Year-to-date, Dorman Products has gained 15.5%, outperforming the Zacks Auto-Tires-Trucks sector, which declined by 8.5%, and the Zacks Automotive - Replacement Parts industry, which fell by 8.2% [1] Earnings and Revenue - Dorman Products has a strong track record of positive earnings surprises, having met or exceeded earnings consensus estimates in the last four quarters [2] - In the latest earnings report on August 4, 2025, Dorman Products reported an EPS of $2.06, surpassing the consensus estimate of $1.76, and beat the revenue estimate by 4.53% [2] - For the current fiscal year, Dorman Products is projected to post earnings of $8.15 per share on revenues of $2.13 billion, reflecting a 14.31% increase in EPS and a 5.98% increase in revenues [3] - For the next fiscal year, the expected earnings are $8.79 per share on revenues of $2.23 billion, indicating a year-over-year change of 7.85% in EPS and 4.77% in revenues [3] Valuation Metrics - Dorman Products currently trades at 18.4 times the current fiscal year EPS estimates, which is a premium compared to the peer industry average of 14 times [7] - On a trailing cash flow basis, the stock trades at 16.5 times, while the peer group's average is 8.5 times [7] - The company has a Value Score of B, a Growth Score of C, and a Momentum Score of A, resulting in a combined VGM Score of B [6] Zacks Rank - Dorman Products holds a Zacks Rank of 2 (Buy), supported by a solid earnings estimate revision trend [8] - The recommendation is for investors to select stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, indicating that Dorman Products is well-positioned for potential gains [8] Industry Comparison - In comparison to industry peers, Douglas Dynamics, Inc. (PLOW) also shows strong performance with a Zacks Rank of 2 (Buy) and a Value Score of A [9] - Douglas Dynamics reported a 35.71% earnings surprise in the last quarter and is expected to post earnings of $2.16 per share on revenues of $644.1 million for the current fiscal year [10] - The Automotive - Replacement Parts industry is performing well, ranking in the top 41% of all industries, suggesting favorable conditions for both Dorman Products and Douglas Dynamics [11]